American Vanguard will acquire all outstanding shares of Tyratech, Inc. Shareholders approved of the agreement and plan of merger and cancellation of admission of Tyratech’s common stock on the AIM market of the London Stock Exchange last Wednesday.
Tyratech is a life sciences company that uses nature-derived products to control insects and parasites. American Vanguard held about 35% of Tyratech’s shares before the acquisition, which is set to close Nov. 8.
“We are excited to have acquired Tyratech, which has spent over a decade developing non-toxic insecticides and green solutions for pest control,” said Eric Wintemute, chairman and CEO of American Vanguard. “Their patended technology platform leverages synergistic essential oil combinations to target invertebrate pest receptors that are not active in humans and other mammals.
“The acquisition complements our Envance portfolio, which uses the same technology platform in consumer, professional and agricultural applications, and will enable us to expand our market into mosquito repellent, animal health and other sectors.”